Viewing data from:

DUTASTERIDE

ANDA

DUTASTERIDE | A209909 | HUMANWELL PURACAP PHARMACEUTICAL WUHAN CO LTD

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: AVODART(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 2 NDCs

Highest NADAC/Unit

$0.1682

per ea

Lowest NADAC/Unit

$0.1682

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
42806054909DUTASTERIDE 0.5 MG CAPSULE	$0.1682	EA	Generic	—	2026-06-17
42806054930DUTASTERIDE 0.5 MG CAPSULE	$0.1682	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain9 active DMFs9 inactive

7 active API suppliers hold Drug Master Files for this ingredient.

STERLING SPADUTASTERIDE

DMF 209182007

MSN LABORATORIES PRIVATE LTDDUTASTERIDE USP [ROUTE CODE - "DT"]

DMF 235332010

DR REDDYS LABORATORIES LTDDUTASTERIDE (PROCESS-II) USP

DMF 264752012

HUBEI GEDIAN HUMANWELL PHARMACEUTICAL CO LTDDUTASTERIDE

DMF 268032013

HUBEI GEDIAN HUMANWELL PHARMACEUTICAL CO LTDDUTASTERIDE ACID

DMF 277632013

HETERO LABS LTDDUTASTERIDE

DMF 277742013

APITORIA PHARMA PRIVATE LTDDUTASTERIDE USP

DMF 295772015

STERLING CHEMICAL MALTA LTDDUTASTERIDE FORM I

DMF 301432015

MSN LABORATORIES PRIVATE LTDDUTASTERIDE USP

DMF 330632018

CATALENT FRANCE BEINHEIM SAInactiveDUTASTERIDE SOFT GELATIN CAPSULES .5MG

DMF 146431999

DR REDDYS LABORATORIES LTDInactiveDUTASTERIDE (Process-I)

DMF 184082005

CIPLA LTDInactiveDUTASTERIDE

DMF 201802009

FIS FABBRICA ITALIANA SINTETICI SPAInactiveDUTASTERIDE

DMF 234942010

GADOR SAInactiveDUTASTERIDE

DMF 238102010

CATALENT PHARMA SOLUTIONS LLCInactiveDUTASTERIDE 0.5 MG SOFT GELATIN CAPSULES

DMF 243042010

RELIANCE LIFE SCIENCES PVT LTDInactiveDUTASTERIDE

DMF 248802011

ZHEJIANG XIANJU PHARMACEUTICAL CO LTDInactiveDUTASTERIDE, NON-STERILE, BULK DRUG SUBSTANCE

DMF 270112013

IND SWIFT LABORATORIES LTDInactiveDUTASTERIDE USP

DMF 277882014

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 0.5MG

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Nov 21, 2017

No patent or exclusivity listings for this strength.